Search alternatives:
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
37021
-
37022
-
37023
-
37024
-
37025
-
37026
Length of stay following cesarean sections: A population based study in the Friuli Venezia Giulia region (North-Eastern Italy), 2005-2015
Published 2019“…Results were expressed as adjusted regression coefficients (aRC) with 95%CI.</p><p>Results</p><p>Although decreasing over the years (5.0 ± 1.7 days in 2005 vs. 4.4 ± 1.7 days in 2015), the pooled mean LoS in the whole FVG during these 11 years was still 4.7 ± 1.7 days, higher than respective international ED benchmark. …”
-
37027
-
37028
Mean of indirect effects per network in relation to recovery biomass of plant–pollinator networks for 2 levels of individual variation and different levels of <i>γ</i><sub>0</sub>....
Published 2024“…<p>(A) Mean net indirect effects, i.e., <i>β</i>, was below zero across different <i>γ</i><sub>0</sub> and for all matrices with spectral radius less than 1. …”
-
37029
Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif
Published 2021“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
-
37030
Image_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.tif
Published 2021“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
-
37031
Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx
Published 2021“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
-
37032
Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx
Published 2021“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
-
37033
Table_3_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx
Published 2021“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
-
37034
Table_2_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.docx
Published 2021“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
-
37035
Table_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.doc
Published 2021“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
-
37036
Table_1_Risk of Venous Thromboembolism in Transgender People Undergoing Hormone Feminizing Therapy: A Prevalence Meta-Analysis and Meta-Regression Study.doc
Published 2021“…When, according to the meta-regression results, the analysis was restricted to series with a mean age ≥37.5 years, the prevalence estimate for VTE increased up to 3% (95%CI:0-5%), but with persistence of a large heterogeneity (I<sup>2 </sup>= 88,2%, P<0.0001); studies on younger participants (<37.5 years) collectively produced a pooled VTE prevalence estimate of 0% (95%CI:0-2%) with no heterogeneity (I<sup>2</sup> = 0%, P=0.97). …”
-
37037
DataSheet1_Response of soil carbon dioxide efflux to temporal repackaging of rainfall into fewer, larger events in a semiarid grassland.pdf
Published 2022“…We found that repackaging rainfall into few/large events with long dry intervals decreased seasonal cumulative F<sub>s</sub>. Repackaging influenced key aspects of pulses including mean, maximum, and antecedent (day before irrigation) values of soil moisture and F<sub>s</sub> and their rate of decline during drying intervals. …”
-
37038
Image_1_Association between elevated homocysteine levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis.tif
Published 2024“…CPAP treatment can significantly decrease serum/plasma HCY levels in patients with OSAHS. …”
-
37039
Image_3_Association between elevated homocysteine levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis.tif
Published 2024“…CPAP treatment can significantly decrease serum/plasma HCY levels in patients with OSAHS. …”
-
37040
Image_2_Association between elevated homocysteine levels and obstructive sleep apnea hypopnea syndrome: a systematic review and updated meta-analysis.tif
Published 2024“…CPAP treatment can significantly decrease serum/plasma HCY levels in patients with OSAHS. …”